Tocilizumab for severe COVID-19 pneumonia

Lancet Rheumatol. 2020 Nov;2(11):e659-e660. doi: 10.1016/S2665-9913(20)30284-8. Epub 2020 Aug 17.

Authors

Salvatore Piano¹, Roberto Vettor¹, Paolo Angeli¹; COVID-LIVER study group

Collaborators

COVID-LIVER study group:
G Arcidiacono, D Benfaremo, S Bettini, B M Bonora, G Bucca, A Cattelan, L Cerruti, A Dalbeni, V Framba, A Gabrielli, C G Gambino, F Ghirardini, U Gnudi, M M Luchetti, A Mantovani, S Mareso, M Marini, A Martini, M Mattioli, L Mucci, G P Perna, F Presotto, C Sensi, R Serra, F Soliani, R Stupia, E Vettore, M Zoncapè

Affiliation

¹ Unit of Internal Medicine and Hepatology, Department of Medicine, University and Hospital of Padova, Padova 35100, Italy.

No abstract available